Real-world clinical practice for advanced non-small-cell lung cancer in the very elderly: A retrospective multicenter analysis

•The PS 0 - 2 patients showed a longer median OS than the PS 3 -4 patients.•Biomarker-matched therapy is effective even in the very elderly.•Biomarker-matched therapy is related to better prognoses, even in the very elderly.•Chemotherapy for biomarker-negative/unknown PS 0 - 2 patients is questionab...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical lung cancer 2022-09, Vol.23 (6), p.532-541
Hauptverfasser:	Fukushima, Takahiro, Oyamada, Yoshitaka, Ikemura, Shinnosuke, Nukaga, Shigenari, Inoue, Takashi, Arai, Daisuke, Ohgino, Keiko, Kuroda, Aoi, Ishioka, Kota, Sakamaki, Fumio, Suzuki, Yusuke, Terai, Hideki, Yasuda, Hiroyuki, Kawada, Ichiro, Fukunaga, Koichi, Soejima, Kenzo
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarker-matched therapy Cytotoxic chemotherapy Immune checkpoint inhibitor Overall survival Tyrosine kinase inhibitor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!